Immediate Management of Carbimazole‑Induced Agranulocytosis

1. Critical First‑Step Interventions

Discontinue carbimazole permanently – The American Thyroid Association recommends that any patient who develops fever, pharyngitis, or other signs of agranulocytosis while on an antithyroid drug must stop the drug immediately. This is a strong guideline recommendation. 1
Do not substitute another thionamide – Cross‑reactivity between carbimazole/methimazole and propylthiouracil is considered absolute; switching to an alternative thionamide is contraindicated in patients with drug‑induced agranulocytosis. (Guideline level: strong recommendation) 1
Admit to hospital for inpatient care – An absolute neutrophil count (ANC) of ≤0.9 × 10⁹/L together with fever fulfills criteria for febrile neutropenia, which requires immediate hospitalization according to oncology standards. (Evidence: consensus guideline) 3

Initiate broad‑spectrum intravenous antibiotics without waiting for cultures – Early empiric therapy reduces mortality, which ranges from 5 % to 36 % in febrile neutropenia depending on severity. (Guideline recommendation) 3
Empiric coverage must include both gram‑positive and gram‑negative organisms – Standard febrile neutropenia protocols call for dual coverage to address the full spectrum of likely pathogens. (Guideline recommendation) 3
Administer granulocyte‑colony stimulating factor (G‑CSF) – Multiple case reports have shown that G‑CSF accelerates neutrophil recovery and improves clinical outcomes in carbimazole‑induced agranulocytosis. (Evidence level: case‑report series) 1

Radioactive iodine (RAI) is the preferred first‑line definitive therapy after agranulocytosis – Endocrine practice guidelines state that RAI should be offered once the patient has recovered from the acute episode; it is highly effective and carries a minimal risk of disease recurrence. (Guideline recommendation) 1
Thyroidectomy is an alternative when RAI is contraindicated or when patient preference dictates – The same guidelines suggest considering near‑total or total thyroidectomy in such scenarios. (Guideline recommendation) 1
Near‑total or total thyroidectomy is the procedure of choice – Endocrine practice guidance specifies that a near‑total or total resection provides the best long‑term control after antithyroid drugs are permanently contraindicated. (Guideline recommendation) 4
Beta‑blockers may be used for symptomatic control of hyperthyroidism during the acute recovery phase – While antithyroid drugs remain contraindicated, beta‑adrenergic blockade can alleviate tachycardia and tremor. (Guideline recommendation) 1

Daily complete blood count (CBC) monitoring until ANC exceeds 1.5 × 10⁹/L – Ensures timely detection of neutrophil recovery and guides the duration of antimicrobial and G‑CSF therapy. (Standard clinical practice; not explicitly cited)
Protective isolation and barrier nursing – Recommended to minimize infection risk while neutropenia persists. (Standard infection‑control practice; not explicitly cited)
Continue antibiotics until neutrophil recovery and fever resolution – Aligns with febrile neutropenia management protocols. (Standard clinical practice; not explicitly cited)